| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CCAAT enhancer binding protein alpha | 0.496 | 0.692 | 0.55 |
|
disease | 1.000 | definitive | 0.985 | 0 | 14 | 1992 | 2020 | ||||||||
|
ETS variant transcription factor 6 | 0.477 | 0.731 | 0.97 |
|
disease | 0.800 | strong | 0.981 | 0 | 2 | 1995 | 2019 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
disease | 0.700 | strong | 1.000 | 0 | 1 | 2003 | 2018 | ||||||||
|
nuclear receptor binding SET domain protein 1 | 0.505 | 0.769 | 1.00 |
|
disease | 0.700 | strong | 1.000 | 0 | 4 | 2002 | 2019 | ||||||||
|
SBDS ribosome maturation factor | 0.601 | 0.692 | 6.2E-05 |
|
disease | 0.620 | strong | 1.000 | 0 | 0 | 2005 | 2017 | ||||||||
|
myeloid leukemia factor 1 | 0.666 | 0.385 | 4.4E-09 |
|
disease | 0.500 | None | 1.000 | 0 | 0 | 1996 | 2019 | ||||||||
|
nucleoporin 214 | 0.638 | 0.385 | 5.5E-02 |
|
disease | 0.500 | None | 1.000 | 0 | 0 | 1999 | 2019 | ||||||||
|
MLLT10 histone lysine methyltransferase DOT1L cofactor | 0.551 | 0.462 | 1.00 |
|
disease | 0.500 | None | 0.958 | 0 | 0 | 1995 | 2019 | ||||||||
|
tet methylcytosine dioxygenase 2 | 0.458 | 0.808 | 4.3E-54 |
|
disease | 0.500 | None | 0.972 | 0 | 0 | 2000 | 2020 | ||||||||
|
core-binding factor subunit beta | 0.601 | 0.538 | 0.96 |
|
disease | 0.500 | None | 0.966 | 0 | 0 | 1993 | 2020 | ||||||||
|
growth factor independent 1 transcriptional repressor | 0.546 | 0.769 | 0.25 |
|
disease | 0.500 | None | 1.000 | 0 | 0 | 2007 | 2020 | ||||||||
|
phosphatidylinositol binding clathrin assembly protein | 0.592 | 0.538 | 1.00 |
|
disease | 0.490 | None | 1.000 | 0 | 0 | 2000 | 2012 | ||||||||
|
LIM domain containing preferred translocation partner in lipoma | 0.543 | 0.769 | 7.2E-03 |
|
disease | 0.410 | None | 1.000 | 0 | 0 | 2001 | 2001 | ||||||||
|
cysteine rich hydrophobic domain 2 | 0.769 | 0.231 | 0.54 |
|
disease | 0.410 | None | 1.000 | 0 | 0 | 1999 | 1999 | ||||||||
|
ASXL transcriptional regulator 1 | 0.482 | 0.808 | 1.3E-14 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 2000 | 2019 | ||||||||
|
SH3 domain containing GRB2 like 1, endophilin A2 | 0.686 | 0.346 | 1.2E-02 |
|
disease | 0.400 | None | 0 | 0 | |||||||||||
|
MPL proto-oncogene, thrombopoietin receptor | 0.510 | 0.692 | 4.1E-09 |
|
disease | 0.200 | None | 1.000 | 0 | 0 | 1998 | 2018 | ||||||||
|
serine and arginine rich splicing factor 2 | 0.561 | 0.731 | 0.48 |
|
disease | 0.200 | None | 0.900 | 0 | 0 | 2000 | 2019 | ||||||||
|
thrombopoietin | 0.513 | 0.692 | 0.20 |
|
disease | 0.200 | None | 1.000 | 0 | 0 | 1995 | 2017 | ||||||||
|
DEAD-box helicase 41 | 0.636 | 0.538 | 5.6E-08 |
|
disease | 0.190 | None | 1.000 | 0 | 1 | 2015 | 2019 | ||||||||
|
elastase, neutrophil expressed | 0.447 | 0.846 | 1.2E-03 |
|
disease | 0.170 | None | 1.000 | 0 | 0 | 2002 | 2018 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.130 | None | 1.000 | 0 | 0 | 2002 | 2017 | ||||||||
|
phosphatidylinositol glycan anchor biosynthesis class A | 0.575 | 0.654 | 0.96 |
|
disease | 0.120 | None | 0.500 | 0 | 0 | 1995 | 2001 | ||||||||
|
ribosomal protein S14 | 0.631 | 0.500 | 0.90 |
|
disease | 0.110 | None | 1.000 | 0 | 0 | 2014 | 2014 | ||||||||
|
dyskerin pseudouridine synthase 1 | 0.547 | 0.769 | 1.00 |
|
disease | 0.110 | None | 1.000 | 0 | 0 | 2009 | 2009 |